pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›FLUTICASONE PROPIONATE
drug · small molecule
save

FLUTICASONE PROPIONATE

Phase 3updated 3mo ago
by Paratek Pharmaceuticals Inc🔗 ChEMBL
Phase 3
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval76 co-mentions · 28 sources
  • drugFlonase Sensimist28 co-mentions · 14 sources
  • drugFluticasone Propionate Glenmark26 co-mentions · 14 sources
  • drugCutivate26 co-mentions · 14 sources
  • drugFlovent26 co-mentions · 14 sources
  • drugFlovent HFA26 co-mentions · 14 sources
  • drugfluticasone furoate14 co-mentions · 14 sources
  • companyAurobindo Pharma Ltd2 co-mentions · 2 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 11 approved and 14 investigational indications.

targets

Glucocorticoid receptor

all catalysts(0)

nothing on the calendar yet

Trials studying FLUTICASONE PROPIONATE

  • phase3A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.not yet recruitingn=188
  • phase4Dymista in Chinese Adolescentsnot yet recruitingn=100
  • phase4A Bronchoscopy Study to Assess the Effects of Inhaled Corticosteroids on Adult Healthy Volunteersactive not recruitingn=30
  • phase2Study on the Safety and Efficacy of PA9159 Inhalation Aerosol for the Treatment of Adult Bronchial Asthmarecruitingn=30
  • phase2Study on BI 54903 (Inhaled Corticosteroid) Administered Twice Daily Via Respimat Inhaler in Patients With Asthma Inadequately Controlled on Medium Dose Inhaled Corticosteroid (ICS).terminatedn=9
  • phase3A Study to Evaluate MK0476 and Fluticasone to Control Asthma in Patients With Mild Persistent Asthma (0476-910)completedn=994
  • phase4Effects of Mometasone Furoate Dry Powder Inhaler, Fluticasone Propionate, and Montelukast on Bone Mineral Density in Asthmatics (Study P03418)completedn=566
  • phase3Study of Inhaled Glucocorticosteroids/Long-Acting Bronchodilator Drugs in Subjects With Asthma That Have Been Taking Inhaled Glucocorticosteroids (Study P04705AM1)completedn=722
more trials →

News(0)

no news has mentioned this drug yet

brand
FLUTICASONE PROPIONATE
trade names
Aerivio spiromax, Airflusal forspiro, Armonair digihaler, Armonair respiclick, Cutivate, Flixonase
generic
FLUTICASONE PROPIONATE
MOA
Glucocorticoid receptor agonist
indication
Nasal Polyps (Nasal Polyposis)
phase
phase_3
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 1h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?